iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
2,136.7
(0.58%)
Feb 27, 2026|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
3,0000%₹354 0%1,700--
--1,720₹1.25 0%7500%
--1,740₹3 0%4,1250%
--1,760₹1.95 -2.5%12,000-41.81%
--1,780₹3 0%3,0000%
1,5000%₹295.3 0%1,800₹2.9 3.57%12,0006.66%
--1,820₹4 17.64%1,8750%
--1,840₹3.75 -14.77%20,2500%
3750%₹202 0%1,860₹4.2 -16.83%22,875-3.17%
4,5000%₹175 0%1,880--
12,0000%₹170 0%1,900₹6.35 -14.18%71,25024.18%
1,5000%₹217.95 0%1,920₹7.35 -13.01%11,250-9.09%
--1,940₹36 0%7500%
--1,960₹10.75 -16.98%19,875-13.11%
1,1250%₹118.5 0%1,980--
1,30,125-1.69%₹171.75 12.84%2,000₹14.8 -22.91%1,14,750-2.23%
8,2500%₹164.15 18.26%2,020₹18.1 -23.3%21,3753.63%
31,5009.09%₹143.25 17.56%2,040₹21.95 -22.84%43,5008.41%
55,875-1.32%₹124.6 14.1%2,060₹26.65 -22.86%58,500105.26%
22,5003.44%₹110.7 16.4%2,080₹32.2 -22.22%33,3758.53%
1,75,875-10.15%₹98.95 17.86%2,100₹38.35 -21.73%87,00049.67%
36,75013.95%₹88.3 20.71%2,120₹45.05 -22.19%27,00026.31%
85,50055.10%₹73.9 17.3%2,140₹55.35 -18.24%60,0002.56%
62,625227.45%₹65.1 20.22%2,160₹64.35 -18.44%23,250416.66%
28,50065.21%₹57.45 23.94%2,180--
1,83,75056.05%₹49 26.61%2,200₹88.35 -14.59%25,500106.06%
18,37532.43%₹41.5 25.75%2,220--
45,00016.50%₹35 27.97%2,240₹169.85 0%2,6250%
20,625223.52%₹28.9 28.73%2,260₹129.3 -11.98%3,75066.66%
84,375-1.74%₹23.5 26%2,280--
64,1250%₹19.65 0%2,300--
94,125-6.69%₹16.75 30.85%2,320₹200.75 0%28,1250%
70,12513.33%₹11 23.59%2,360--
79,5000%₹8.2 0%2,400--

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.